tiprankstipranks
Praxis Precision Medicines (PRAX)
NASDAQ:PRAX
US Market
PRAX
Praxis Precision Medicines
RESEARCH TOOLSreports

Praxis Precision Medicines (PRAX) Stock News & Sentiment

949 Followers
3 Best Stocks to Buy Today, 4/7/2026, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Today, 4/7/2026, According to Top Analysts
2d ago
IVA
OVID
Praxis: EMBRAVE Data Validate Elsunersen and De‑Risk Pipeline, Supporting Buy Rating on Favorable Risk‑Reward
Premium
Ratings
Praxis: EMBRAVE Data Validate Elsunersen and De‑Risk Pipeline, Supporting Buy Rating on Favorable Risk‑Reward
2d ago
PRAX
Praxis reports positive elsunersen trial in pediatric epilepsies
Premium
Company Announcements
Praxis reports positive elsunersen trial in pediatric epilepsies
3d ago
8K
PRAX
Praxis Precision Medicines: Advancing Late-Stage Neurology Pipeline Underpins Outperform Rating and $53 Price Target
Premium
Ratings
Praxis Precision Medicines: Advancing Late-Stage Neurology Pipeline Underpins Outperform Rating and $53 Price Target
3d ago
PRAX
Praxis Precision Medicines Maps Aggressive Path to Market
Premium
Company Announcements
Praxis Precision Medicines Maps Aggressive Path to Market
2M ago
PRAX
Praxis Therapeutics: Advancing Late-Stage Neurology Pipeline Toward Commercialization with Multibillion-Dollar Market Potential
Premium
Ratings
Praxis Therapeutics: Advancing Late-Stage Neurology Pipeline Toward Commercialization with Multibillion-Dollar Market Potential
2M ago
PRAX
Praxis Precision Medicines: NDA Progress, Robust Pipeline, and Strong Cash Runway Support Buy Rating
Premium
Ratings
Praxis Precision Medicines: NDA Progress, Robust Pipeline, and Strong Cash Runway Support Buy Rating
2M ago
PRAX
More PRAX News >

PRAX News on the Web

Top Analysts Are Loading Up on These 3 Stocks Right Now
TipRanks News
Bullish
Praxis: EMBRAVE Data Validate Elsunersen and De‑Risk Pipeline, Supporting Buy Rating on Favorable Risk‑Reward
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Adagene (ADAG), Caribou Biosciences (CRBU) and Praxis Precision Medicines (PRAX)
TipRanks News
Bullish
Praxis reports positive elsunersen trial in pediatric epilepsies
TipRanks News
Neutral
Praxis Precision Medicines: Advancing Late-Stage Neurology Pipeline Underpins Outperform Rating and $53 Price Target
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: PDS Biotechnology (PDSB), Eli Lilly & Co (LLY) and Praxis Precision Medicines (PRAX)
TipRanks News
Bullish
Why Praxis Precision Medicines Shares Are Sinking Now
TipRanks News
Bullish
Praxis Precision announces topline results from EMBRAVE Part A trial
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
PRAX
Sector Average
Media Buzz
This Week8 articles
Weekly Average5.5 articles
News Sentiment
This Week100%
Sector Average69%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is PRAX’s Media Buzz Sentiment?
8 articles about PRAX were published this week. In an average week, 5.5 articles are published.
    What is PRAX’s weekly average amount of articles?
    In an average week, 5.5 articles about PRAX are published.
      What is PRAX’s News Sentiment?
      100% of articles about PRAX were positive this week, compared to its sector average of 69%.
        Healthcare Stocks that are Trending in the News
        NBIXNeurocrine
        STAAStaar Surgical
        AORTArtivion
        OWLTOwlet
        HUMHumana
        Showing the stocks with the most bullish news sentiment over the past week